Clene (CLNN) Change in Receivables (2020 - 2025)
Clene (CLNN) posted Change in Receivables of -$64000.0 for Q1 2025, down 200.0% on a QoQ basis from $64000.0 in Q4 2024, and up 18.99% year-over-year from -$53787.2 in Q1 2024.
Powered by 
Analysis
Clene (CLNN) Change in Receivables (2020 - 2025) Analysis & Trends
Clene has reported Change in Receivables for 6 years, with the latest figure at -$64000.0 in Q1 2025.
- On a quarterly basis, Change in Receivables rose 18.99% year-over-year to -$64000.0 in Q1 2025; TTM through Dec 2025 was -$64000.0, a 18.99% increase from a year earlier, with the FY2025 full-year figure at -$64000.0, up 18.99% from the prior year.
- Change in Receivables was -$64000.0 for Q1 2025 at Clene, down from $64000.0 in the prior quarter.
- The five-year high for Change in Receivables was $126000.0 in Q3 2022, with the low at -$126000.0 in Q1 2023.
- Average Change in Receivables over 5 years is -$1500.0, with a median of -$34500.0 recorded in 2021.
- The sharpest annual moves came in 2022 and 2023: Change in Receivables jumped 415.0% in 2022, then slumped 176.98% in 2023.
- Over 5 years, Change in Receivables stood at -$20000.0 in 2021, then surged by 415.0% to $63000.0 in 2022, then climbed by 25.4% to $79000.0 in 2023, then slipped by 18.99% to $64000.0 in 2024, then slumped by 200.0% to -$64000.0 in 2025.
- The last three Change in Receivables figures came in at -$64000.0 (Q1 2025), $64000.0 (Q4 2024), and -$64000.0 (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 73.80 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | -1.70 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -64,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Jun 30, 2024 | -64,000.00 |
| Mar 31, 2024 | -79,000.00 |
| Dec 31, 2023 | 79,000.00 |
| Sep 30, 2023 | -97,000.00 |
| Jun 30, 2023 | 98,000.00 |
| Mar 31, 2023 | -126,000.00 |
| Dec 31, 2022 | 63,000.00 |
| Sep 30, 2022 | 126,000.00 |
| Mar 31, 2022 | -49,000.00 |
| Dec 31, 2021 | -20,000.00 |
| Jun 30, 2021 | -55,000.00 |
| Mar 31, 2021 | 103,000.00 |
| Mar 31, 2020 | 70,000.00 |